Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
330
NCT03692806
Efficacy of STABLOR® on Visceral Fat Mass Reduction in Patients With Metabolic Syndrome
Phase: N/A
Role: Lead Sponsor
Start: Sep 11, 2018
Completion: Dec 16, 2020
NCT06995573
A Study to Assess Safety and Tolerability and to Explore Efficacy of NSC001 in Mild to Moderate Alzheimer's Disease
Phase: Phase 1/2
Start: Jun 30, 2025
Completion: Sep 30, 2026